approved EB-2 (NIW)

Graduate Research Assistant

Machine Learning · Bangladesh · 2025-06-03

Processing Time
344 days
Decision Date
2025-06-03
Location
South Carolina
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop advanced AI models, specifically graph neural networks and deep learning architectures, for predicting drug-target interactions and optimizing drug compounds. This work aims to revolutionize drug discovery, accelerate molecular simulations, and facilitate the identification of crystal structures for pharmaceutical and optoelectronic applications.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor supports national public health and technology infrastructure, aligning with federal AI executive orders.

2 Well-positioned to Advance the Endeavor Met

The petitioner demonstrated success through high-impact publications and securing funding from major federal agencies like the NSF and NASA.

3 Waiver Benefit to the U.S. Met

The national scope of the benefits and the critical nature of AI innovation made it beneficial to waive the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 4 peer-reviewed publications with 82 citations, including papers in the top 1% and 10% of their field. Evidence of national significance was provided through funding from NASA EPSCoR and the National Science Foundation. The case successfully satisfied all three Dhanasar prongs by demonstrating the endeavor's alignment with the 2023 Executive Order on AI.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Original Contributions
Government Alignment

Similar Cases

Consultant

Engineering · India

WeGreened EB-2 (NIW) approved
New Jersey 45 days 2025-01-16
The petitioner proposes to continue research on developing advanced machine learning, artificial intelligence, and language modeling frameworks by integrating data-driven methods with domain knowledge. This work aims to address key challenges in drug development and healthcare, specifically focusing on accelerating drug discovery, optimizing clinical trials, and enhancing manufacturing efficiency.

Others

Information Technology · China

WeGreened EB-2 (NIW) approved
317 days 2026-02-21
The petitioner proposes to develop advanced deep learning models to improve the understanding of structure-function relationships in large biomolecules. This work aims to enable more accurate target identification, better candidate design, and more efficient therapeutic optimization for complex diseases. The endeavor specifically targets bottlenecks in drug development to reduce the high failure rate and cost of new drug candidates.

Others

Research and Development · China

WeGreened EB-2 (NIW) approved
285 days 2025-02-02
The petitioner proposes to develop state-of-the-art machine learning methods for multiscale computational chemistry modeling to support the design and discovery of advanced materials and therapeutics. This work focuses on creating peptide, antibody, and small molecule therapies for treating cancer, obesity, and autoimmune diseases.

Chief Executive Officer (CEO)

Artificial Intelligence · Syria

WeGreened EB-2 (NIW) approved
200 days 2025-06-25
The petitioner proposes to lead scientific initiatives building machine learning models that accelerate the drug discovery process, specifically focusing on simulating molecular interactions to design personalized cancer treatments. Her work aims to address bottlenecks in drug development by blending multi-omics data with predictive AI systems to reduce costs and increase precision.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-06-03.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 344 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist